Let’s analyze the Apollo Hospitals share price target 2025 based on the companies’ technical data and market value.
Apollo Hospitals Enterprise Limited, based in Chennai, is the largest for-profit private hospital network in India.
The company manages a robust network of 71 hospitals, pharmacies, primary care and diagnostic centers, telehealth clinics, and digital healthcare services through its subsidiaries.
Founded in 1983 by Prathap C. Reddy, Apollo Hospitals was the first corporate healthcare provider in India, and several of its hospitals have received international healthcare accreditation from the Joint Commission International (JCI) and NABH accreditation.
Apollo Hospitals Share Price Target 2025
Considering Apollo Hospitals’ robust financial performance and growth trends, we project the share price for 2025 to be in the range of 8,500 to 9,000 INR.
This projection is based on the company’s consistent revenue growth, improving profit margins, and strong market position in the healthcare sector. Here’s a month-by-month prediction for 2025:
Apollo Hospitals Share Price Target 2025 Monthly
| Month | Predicted Share Price |
|---|---|
| January | 7,000 |
| February | 7,200 |
| March | 7,350 |
| April | 7,500 |
| May | 7,650 |
| June | 7,800 |
| July | 7,950 |
| August | 8,100 |
| September | 8,250 |
| October | 8,400 |
| November | 8,600 |
| December | 8,800 |
Financial Highlights and Quarterly Performance
Quarterly Results (Figures in INR Crores)
| Quarter | Sales | Expenses | Operating Profit | OPM % | Other Income | Interest | Depreciation | Profit Before Tax | Net Profit | EPS (INR) |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2021 | 2,868 | 2,456 | 412 | 14% | 63 | 99 | 138 | 238 | 170 | 11.67 |
| Jun 2021 | 3,760 | 3,244 | 516 | 14% | 319 | 95 | 141 | 599 | 501 | 34.03 |
| Sep 2021 | 3,717 | 3,102 | 615 | 17% | 8 | 95 | 145 | 383 | 267 | 17.24 |
| Dec 2021 | 3,639 | 3,052 | 587 | 16% | 23 | 94 | 149 | 367 | 243 | 15.88 |
| Mar 2022 | 3,546 | 3,083 | 463 | 13% | 34 | 95 | 166 | 236 | 97 | 6.27 |
| Jun 2022 | 3,796 | 3,317 | 479 | 13% | 16 | 93 | 148 | 254 | 324 | 22.06 |
| Sep 2022 | 4,251 | 3,699 | 552 | 13% | 23 | 93 | 155 | 327 | 213 | 14.19 |
| Dec 2022 | 4,264 | 3,780 | 484 | 11% | 35 | 100 | 153 | 266 | 162 | 10.68 |
| Mar 2023 | 4,302 | 3,814 | 488 | 11% | 20 | 95 | 159 | 254 | 146 | 10.05 |
| Jun 2023 | 4,418 | 3,909 | 509 | 12% | 34 | 106 | 167 | 270 | 173 | 11.59 |
| Sep 2023 | 4,847 | 4,219 | 628 | 13% | 26 | 111 | 163 | 379 | 249 | 16.20 |
| Dec 2023 | 4,851 | 4,237 | 614 | 13% | 29 | 113 | 167 | 363 | 254 | 17.06 |
| Mar 2024 | 4,944 | 4,303 | 640 | 13% | 37 | 119 | 190 | 368 | 258 | 17.65 |
Apollo Hospitals has consistently shown strong sales growth and profitability. The operating profit margins have remained healthy, despite fluctuations in other income and expenses.
Annual Financial Performance
Profit & Loss (Figures in INR Crores)
| Year | Sales | Expenses | Operating Profit | OPM % | Other Income | Interest | Depreciation | Profit Before Tax | Net Profit | EPS (INR) | Dividend Payout % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2013 | 3,769 | 3,157 | 612 | 16% | 33 | 103 | 142 | 399 | 303 | 21.88 | 25% |
| Mar 2014 | 4,357 | 3,681 | 676 | 16% | 18 | 119 | 168 | 407 | 315 | 22.77 | 25% |
| Mar 2015 | 5,129 | 4,392 | 737 | 14% | 47 | 118 | 212 | 455 | 335 | 24.43 | 24% |
| Mar 2016 | 6,150 | 5,465 | 684 | 11% | 92 | 180 | 264 | 332 | 235 | 16.99 | 35% |
| Mar 2017 | 7,256 | 6,522 | 734 | 10% | 60 | 257 | 314 | 222 | 131 | 15.88 | 38% |
| Mar 2018 | 8,243 | 7,442 | 801 | 10% | 24 | 295 | 359 | 171 | 60 | 8.44 | 59% |
| Mar 2019 | 9,617 | 8,548 | 1,070 | 11% | 26 | 327 | 396 | 373 | 200 | 16.96 | 35% |
| Mar 2020 | 11,247 | 9,656 | 1,591 | 14% | 222 | 533 | 620 | 660 | 432 | 32.70 | 18% |
| Mar 2021 | 10,560 | 9,420 | 1,140 | 11% | 103 | 449 | 573 | 221 | 137 | 10.46 | 29% |
| Mar 2022 | 14,663 | 12,474 | 2,189 | 15% | 368 | 379 | 601 | 1,578 | 1,108 | 73.42 | 16% |
| Mar 2023 | 16,612 | 14,548 | 2,065 | 12% | 75 | 381 | 615 | 1,144 | 844 | 56.97 | 26% |
| Mar 2024 | 19,059 | 16,668 | 2,391 | 13% | 126 | 449 | 687 | 1,380 | 935 | 62.50 | 10% |
Apollo Hospitals has demonstrated steady growth in both sales and profits over the past decade, with notable improvements in operating profit margins and earnings per share (EPS).
Shareholding Pattern
Quarterly and Yearly Shareholding (in %)
| Holder Type | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 29.82% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% |
| FIIs | 51.54% | 52.41% | 50.81% | 48.48% | 49.09% | 47.94% | 46.96% | 47.93% | 46.15% | 46.25% | 45.63% | 43.92% |
| DIIs | 12.28% | 12.17% | 12.93% | 15.64% | 15.28% | 16.56% | 17.76% | 17.02% | 18.59% | 18.87% | 19.55% | 21.13% |
| Government | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| Public | 6.14% | 5.86% | 6.70% | 6.32% | 6.07% | 5.94% | 5.72% | 5.49% | 5.68% | 5.32% | 5.26% | 5.38% |
Compounded Annual Growth Rates (CAGR) and Return on Equity
- Sales Growth:
- 10 Years: 16%
- 5 Years: 15%
- 3 Years: 22%
- Trailing Twelve Months (TTM): 15%
- Profit Growth:
- 10 Years: 11%
- 5 Years: 35%
- 3 Years: 110%
- TTM: 11%
- Stock Price CAGR:
- 10 Years: 20%
- 5 Years: 36%
- 3 Years: 16%
- 1 Year: 22%
- Return on Equity:
- 10 Years: 9%
- 5 Years: 12%
- 3 Years: 15%
- Last Year: 14%
Conclusion
Apollo Hospitals continues to exhibit strong financial health and growth prospects. With its significant market presence and continuous expansion in healthcare services, the Apollo Hospitals share price target 2025 is likely to see substantial appreciation.
Investors can consider Apollo Hospitals a promising long-term investment in the healthcare sector, benefiting from its solid historical performance and future growth potential.